1. Home
  2. ARLO vs IMCR Comparison

ARLO vs IMCR Comparison

Compare ARLO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$12.57

Market Cap

1.6B

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$36.86

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARLO
IMCR
Founded
2018
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
ARLO
IMCR
Price
$12.57
$36.86
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$24.00
$66.33
AVG Volume (30 Days)
1.3M
390.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
145.16
30.39
EPS
0.16
0.23
Revenue
N/A
$249,428,000.00
Revenue This Year
$9.29
$14.57
Revenue Next Year
$8.82
$8.21
P/E Ratio
$82.19
$157.91
Revenue Growth
N/A
43.05
52 Week Low
$11.05
$27.56
52 Week High
$19.94
$40.71

Technical Indicators

Market Signals
Indicator
ARLO
IMCR
Relative Strength Index (RSI) 36.99 61.32
Support Level $12.19 $35.46
Resistance Level $14.00 $37.38
Average True Range (ATR) 0.46 1.15
MACD -0.15 -0.00
Stochastic Oscillator 8.33 83.19

Price Performance

Historical Comparison
ARLO
IMCR

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. Its cloud-based platform provides users with visibility, insight, and a powerful means to help protect and connect in real-time with the people and things that matter, from any location with a Wi-Fi or cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: